These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23938313)

  • 21. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.
    Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Mov Disord; 2005 Dec; 20(12):1571-6. PubMed ID: 16116613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
    Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
    Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
    Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry.
    Beyer MK; Janvin CC; Larsen JP; Aarsland D
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):254-9. PubMed ID: 17028119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive status correlates with white matter alteration in Parkinson's disease.
    Hattori T; Orimo S; Aoki S; Ito K; Abe O; Amano A; Sato R; Sakai K; Mizusawa H
    Hum Brain Mapp; 2012 Mar; 33(3):727-39. PubMed ID: 21495116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional volumetric change in Parkinson's disease with cognitive decline.
    Gee M; Dukart J; Draganski B; Wayne Martin WR; Emery D; Camicioli R
    J Neurol Sci; 2017 Feb; 373():88-94. PubMed ID: 28131236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry.
    Lee JE; Park B; Song SK; Sohn YH; Park HJ; Lee PH
    Mov Disord; 2010 Jan; 25(1):28-34. PubMed ID: 19908327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
    Pereira JB; Hall S; Jalakas M; Grothe MJ; Strandberg O; Stomrud E; Westman E; van Westen D; Hansson O
    Neurobiol Dis; 2020 Jun; 139():104831. PubMed ID: 32145376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of cortical thinning in nondemented Parkinson's disease patients.
    Uribe C; Segura B; Baggio HC; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Mov Disord; 2016 May; 31(5):699-708. PubMed ID: 27094093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study.
    Summerfield C; Junqué C; Tolosa E; Salgado-Pineda P; Gómez-Ansón B; Martí MJ; Pastor P; Ramírez-Ruíz B; Mercader J
    Arch Neurol; 2005 Feb; 62(2):281-5. PubMed ID: 15710857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
    Low A; Foo H; Yong TT; Tan LCS; Kandiah N
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):681-687. PubMed ID: 30683708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.
    Pan PL; Shi HC; Zhong JG; Xiao PR; Shen Y; Wu LJ; Song YY; He GX; Li HL
    Neurol Sci; 2013 May; 34(5):613-9. PubMed ID: 23184330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment.
    Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G
    Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
    Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.